ABEO - ABEONA THERAPEUTICS INC.
5.01
-0.130 -2.595%
Share volume: 1,526,156
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$5.14
-0.13
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-14-2024 | 03-20-2025 | 05-15-2025 | 08-14-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 74.828 M | 134.003 M | 120.592 M | 108.931 M | 99.364 M | 246.233 M | 231.095 M | |
| Current Assets | 66.725 M | 125.904 M | 112.657 M | 100.853 M | 88.121 M | 232.262 M | 216.130 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.686 M | 4.850 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 44.786 M | 88.282 M | 93.975 M | 74.363 M | 68.219 M | 61.983 M | 124.233 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 17.558 M | 34.426 M | 15.726 M | 23.357 M | 15.936 M | 163.535 M | 82.884 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.767 M | 3.975 M | 4.058 M | 4.430 M | 6.947 M | 9.489 M | 10.338 M | |
| Other Assets | 4.336 M | 4.124 M | 3.877 M | 3.648 M | 4.296 M | 4.482 M | 4.627 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 74.828 M | 134.003 M | 120.592 M | 108.931 M | 99.364 M | 246.233 M | 231.095 M | |
| Total liabilities | 83.709 M | 60.762 M | 74.819 M | 64.900 M | 57.968 M | 82.657 M | 59.862 M | |
| Total current liabilities | 11.889 M | 16.843 M | 18.422 M | 16.587 M | 17.983 M | 34.517 M | 22.180 M | |
| Accounts Payable | 3.362 M | 3.099 M | 2.789 M | 3.441 M | 5.018 M | 7.337 M | 5.927 M | |
| Other liabilities | 53.741 M | 27.786 M | 42.191 M | 35.276 M | 28.847 M | 34.135 M | 26.820 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 18.079 M | 16.133 M | 14.206 M | 13.037 M | 11.138 M | 14.005 M | 10.862 M | |
| Other liabilities | 53.741 M | 27.786 M | 42.191 M | 35.276 M | 28.847 M | 34.135 M | 26.820 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -8.881 M | 73.241 M | 45.773 M | 44.031 M | 41.396 M | 163.576 M | 171.233 M | |
| Common stock | 772.405 M | 847.071 M | 849.822 M | 857.281 M | 866.750 M | 880.075 M | 892.838 M | |
| Retained earnings | -781.102 M | -773.696 M | -803.965 M | -813.258 M | -825.287 M | -716.454 M | -721.615 M |